Hélène Haegel
Keine laufenden Positionen mehr
Profil
Hélène Haegel was the founder of ElsaLys Biotech SAS, where she held the title of Head-Preclinical Biology Department until she became inactive.
The company was founded in 2013.
Ehemalige bekannte Positionen von Hélène Haegel
| Unternehmen | Position | Ende |
|---|---|---|
| ELSALYS BIOTECH | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ElsaLys Biotech SAS
 ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
